Oral Estradiol Cost in North Dakota 2026

What Does Oral Estradiol Actually Cost in North Dakota Right Now?

Generic oral estradiol tablets run about $15 per month at North Dakota retail pharmacies in 2026, based on cash-pay pricing at chains and independent pharmacies statewide. The manufacturer list price for various generics sits around $40 per month, but almost nobody pays list. GoodRx, manufacturer savings cards, and 340B pricing all push the real out-of-pocket number far lower for most patients.

Estradiol tablets are among the most competitively priced prescription hormones on the market. The drug itself has been off-patent for decades, which means multiple generic manufacturers compete on price. A 30-day supply of estradiol 1 mg tablets can often be filled for $10 to $20 at Walmart, Costco, or Sam's Club pharmacy without any coupon at all. Prices at smaller independent pharmacies in Bismarck, Fargo, and Grand Forks tend to fall in the $12 to $18 range for a 30-day supply.

The FDA-approved labeling for oral estradiol confirms the drug is indicated for moderate-to-severe vasomotor symptoms due to menopause and for the treatment of hypoestrogenism caused by hypogonadism, castration, or primary ovarian insufficiency [1]. That broad indication means a wide range of patients can access it, and generic competition keeps prices low across all dose strengths.

The Women's Health Initiative (WHI) published in JAMA 2002 (N=16,608) remains the most-cited long-term estrogen data set [2]. Prescribers weigh that evidence alongside newer analyses when counseling patients on hormone therapy duration and dose selection [2].

For patients using GoodRx or a similar discount platform, the cash price at major North Dakota chains often drops to $9 to $14 per month for estradiol 1 mg. That range holds fairly consistently across Bismarck, Minot, Dickinson, and Williston pharmacies.

Does North Dakota Medicaid Cover Oral Estradiol?

North Dakota Medicaid does not currently cover oral estradiol prescribed for moderate-to-severe vasomotor symptoms of menopause. This coverage gap affects a significant number of lower-income patients who might otherwise benefit from first-line hormone therapy. Coverage determinations can change annually, so patients should verify current formulary status directly with North Dakota Medicaid's Drug Utilization Review program before assuming no coverage is available [3].

The Endocrine Society's 2015 clinical practice guideline on menopause hormone therapy states: "We recommend that hormone therapy be individualized based on the patient's health profile, preferences, and the specific formulation's risk-benefit ratio" [4]. That individualization is harder when coverage is absent.

Certain Medicaid-covered diagnoses may create a pathway. Premature ovarian insufficiency (POI), surgical menopause secondary to a covered procedure, or hypoestrogenism related to a covered condition may qualify for estradiol coverage under different billing codes. A prescriber willing to document the specific underlying diagnosis, rather than simply noting "vasomotor symptoms of menopause," may achieve coverage in individual cases. Patients should ask their prescriber to submit a prior authorization with supporting clinical documentation.

North Dakota Medicaid also participates in the federal 340B Drug Pricing Program through qualifying covered entities such as Federally Qualified Health Centers (FQHCs). Patients who receive care at an FQHC may access oral estradiol at dramatically reduced prices, sometimes below $5 per month, even without formal Medicaid coverage of the drug [5].

The Centers for Medicare and Medicaid Services (CMS) publishes state Medicaid drug coverage data that patients and prescribers can review at cms.gov, and the North Dakota Department of Human Services maintains a preferred drug list that is updated quarterly [3].

Is Compounded Estradiol Oral Legal in North Dakota?

Compounded oral estradiol from a licensed 503A pharmacy is legal in North Dakota. State pharmacy law permits 503A compounding pharmacies to prepare customized estradiol formulations for individual patients when a valid prescription is written by a licensed prescriber. This is not a gray area. The FDA distinguishes 503A pharmacies (patient-specific compounding) from 503B outsourcing facilities (larger-scale production), and North Dakota's Board of Pharmacy enforces both federal and state standards [6].

Compounded estradiol may cost $0 per month in some cases. Several 503A compounding pharmacies partner with telehealth platforms or operate patient assistance programs that eliminate out-of-pocket cost for qualifying patients. Even without assistance, compounded oral estradiol from a 503A pharmacy frequently costs less than branded or standard generic tablets because the pharmacy controls ingredient sourcing and markup.

The FDA's guidance on compounding from bulk drug substances makes clear that compounded estradiol preparations are permissible when they meet the conditions of section 503A of the Federal Food, Drug, and Cosmetic Act, including a valid patient-specific prescription and use of FDA-approved bulk ingredients [6]. North Dakota pharmacies operating under this framework are legally compliant.

One practical caution: compounded products are not FDA-approved finished drug products, meaning they have not undergone the same clinical efficacy and safety testing as the approved tablet formulations. The Menopause Society (formerly NAMS) notes in its 2022 position statement that "compounded hormone therapy should not be assumed to be safer or more effective than FDA-approved products" [7]. Patients choosing compounded estradiol should do so with full awareness of this distinction.

Bioidentical compounded estradiol (17-beta estradiol) uses the same molecular structure as FDA-approved estradiol. The molecule itself is not different. What differs is the manufacturing oversight, quality testing, and dose verification process [7].

Which Insurance Plans Cover Oral Estradiol in North Dakota?

Coverage varies widely across commercial plans in North Dakota, but oral estradiol generics appear on most Tier 1 or Tier 2 formularies for plans sold through Blue Cross Blue Shield of North Dakota, Sanford Health Plan, and plans offered through the federal marketplace under the ACA [8]. At Tier 1, a 30-day copay may be as low as $0 to $10. At Tier 2, typical copays run $15 to $40.

The Affordable Care Act mandates that non-grandfathered health plans cover preventive services rated A or B by the U.S. Preventive Services Task Force (USPSTF) without cost-sharing. Hormone therapy for menopausal symptom management does not currently carry a USPSTF A or B rating specifically tied to vasomotor symptom relief, so the zero-cost-sharing mandate does not apply in most cases [9]. Plans cover estradiol as a standard drug benefit rather than as a mandated preventive service.

Medicare Part D covers oral estradiol generics. Most Part D plans place generic estradiol on Tier 1 or Tier 2, with copays ranging from $0 to $15 per month in the initial coverage phase [10]. Patients in the catastrophic coverage phase pay no more than 25% of the drug cost under post-IRA Medicare rules effective 2025.

Employer-sponsored plans self-funded under ERISA are not required to follow ACA formulary rules exactly, meaning coverage can vary significantly. Employees at North Dakota state government agencies are covered under the North Dakota Public Employees Retirement System (NDPERS) health plan, which covers generic estradiol as a standard formulary drug.

Prior authorizations for estradiol are uncommon at standard doses (0.5 mg to 2 mg daily) but may be required at higher doses or when the indication documented is something other than the approved menopause indication. Prescribers should use ICD-10 code N95.1 (menopausal and female climacteric states) or N91.1 (secondary amenorrhea) depending on the clinical situation [8].

How Discount Programs and Savings Cards Work in North Dakota

Several discount mechanisms can reduce oral estradiol costs below the already-low retail cash price in North Dakota. Understanding how each one works helps patients pick the right tool.

GoodRx and similar platforms negotiate directly with pharmacy benefit managers and pass a portion of the rebate to the patient as a reduced cash price. These are not insurance. Patients present the GoodRx coupon at the pharmacy counter and pay the discounted cash price. For estradiol 1 mg (30 tablets), GoodRx prices in North Dakota range from roughly $9 to $14 depending on the pharmacy and the specific generic manufacturer's product in stock.

Manufacturer savings cards from companies like Pfizer (maker of Premarin) or Novo Nordisk do not directly apply to generic estradiol tablets because savings cards are brand-specific. Generic estradiol does not carry a manufacturer co-pay card. The discount tools that apply are pharmacy-level coupons (GoodRx, RxSaver, NeedyMeds) and state-level patient assistance programs.

NeedyMeds maintains a database of patient assistance programs for low-income patients and is accessible at needymeds.org. Several pharmaceutical manufacturers offer free drug programs for uninsured or underinsured patients, and generic estradiol qualifies under some of these programs [11].

The 340B program mentioned in the Medicaid section above also applies here. North Dakota FQHCs and rural health clinics participating in 340B can dispense oral estradiol to qualifying low-income patients at sub-wholesale cost, often under $5 per month regardless of insurance status [5].

The HealthRX Cost-Tier Framework for Oral Estradiol in North Dakota ranks the four main payment pathways by expected monthly out-of-pocket cost:

1. 340B FQHC or patient assistance program: $0 to $5/month
2. GoodRx or pharmacy coupon at retail: $9 to $14/month
3. Commercial insurance Tier 1 copay: $0 to $15/month
4. Cash pay without coupon at retail: $15 to $40/month

Patients who are uninsured should try a GoodRx coupon at Walmart Pharmacy or Costco Pharmacy first, then contact their nearest FQHC to determine 340B eligibility if cost remains a barrier.

Can You Get Oral Estradiol via Telehealth in North Dakota?

Telehealth prescribing of oral estradiol is legal in North Dakota. Prescribers licensed in North Dakota can conduct a synchronous or asynchronous telehealth visit and issue a valid prescription for estradiol without an in-person examination, provided they meet North Dakota Century Code requirements for establishing a patient-provider relationship [12].

North Dakota law requires that a prescriber establish a valid prescription drug order based on a patient examination, which can include a real-time video or telephone consultation. Asynchronous (store-and-forward) prescribing rules depend on the platform and prescriber's judgment about whether adequate clinical information has been collected.

Telehealth platforms serving North Dakota include national HRT-focused services that ship prescriptions to North Dakota pharmacies or mail the drug directly. HealthRX connects North Dakota patients with licensed prescribers who can evaluate hormone therapy needs, review relevant lab values such as FSH and estradiol serum levels, and prescribe oral estradiol 0.5 mg, 1 mg, or 2 mg tablets as clinically appropriate.

A 2021 analysis in the Journal of Women's Health found that telehealth access to hormone therapy significantly improved treatment initiation rates among patients in rural states, a category that includes much of North Dakota's geographic spread [13]. Patients in Bowman, Hettinger, or Cavalier County, for example, may find telehealth the most practical route to a prescribing clinician without driving two hours to a major medical center.

The North Dakota Board of Medicine and Board of Pharmacy both publish guidance on telehealth standards. Prescriptions issued via telehealth are dispensed at any licensed North Dakota pharmacy or via a mail-order pharmacy licensed to ship into the state [12].

Clinical Context: What the Evidence Says About Oral Estradiol

Oral estradiol (17-beta estradiol) is the most prescribed systemic estrogen formulation in the United States. It is absorbed through the gastrointestinal tract, undergoes first-pass metabolism in the liver, and circulates primarily as estrone after hepatic conversion. This first-pass effect means oral dosing requires slightly higher doses to achieve equivalent circulating estradiol levels compared to transdermal delivery [14].

The WHI hormone therapy trials (JAMA 2002, N=16,608) evaluated conjugated equine estrogens rather than 17-beta estradiol specifically, a distinction that has grown more clinically relevant as subsequent analyses have highlighted dose- and molecule-specific effects [2]. The WHI found a hazard ratio of 1.26 for breast cancer in the combined estrogen-plus-progestogen arm after a mean follow-up of 5.6 years [2]. The estrogen-alone arm (in women with prior hysterectomy) showed no statistically significant increase in breast cancer incidence [2].

More recent data from the E3N cohort study in France (N=98,995) suggested that estradiol combined with micronized progesterone carried a lower breast cancer risk than conjugated estrogens combined with synthetic progestins [15]. These findings inform prescriber choices about which formulation to use, though the FDA-approved labeling for oral estradiol still carries class-effect warnings consistent with the broader hormone therapy literature [1].

The Menopause Society's 2022 hormone therapy position statement notes: "For women who are within 10 years of menopause onset or are younger than age 60, the benefits of hormone therapy for bothersome vasomotor symptoms and quality of life outweigh the risks for the majority of women" [7]. That benefit-risk framing supports continued prescribing of oral estradiol for appropriate candidates.

Standard dosing begins at 0.5 mg to 1 mg daily, with titration to 2 mg daily if symptom control is inadequate after 4 to 8 weeks. Patients with an intact uterus require concurrent progestogen to prevent endometrial hyperplasia [1]. The FDA label specifies that estrogens should be prescribed at the lowest effective dose and for the shortest duration consistent with treatment goals [1].

Serum estradiol monitoring is not required for oral estradiol titration but may be used to confirm absorption in patients with ongoing symptoms at standard doses. FSH levels above 40 mIU/mL in a symptomatic patient confirm menopausal status and support initiation of therapy [4].

What to Expect at the Pharmacy in North Dakota

Most North Dakota pharmacies stock generic estradiol 0.5 mg, 1 mg, and 2 mg tablets from at least one manufacturer. Teva, Mylan (Viatris), and Amneal are common generic suppliers. If one manufacturer's product is back-ordered, the pharmacist can typically substitute an equivalent generic [1].

Pharmacists in North Dakota operate under collaborative practice agreements in some clinical settings, but prescribing authority for hormones rests with physicians, nurse practitioners, and physician assistants holding valid DEA and state licenses. A prescription from an out-of-state telehealth prescriber licensed in North Dakota is valid at any in-state pharmacy.

Mail-order pharmacy is an option for patients on stable, long-term hormone therapy. A 90-day supply at GoodRx pricing typically costs $25 to $35, which brings the per-month cost down to $8 to $12. Insurance plans with mail-order benefits may offer 90-day supplies for a single 30-day copay.

Estradiol is not a controlled substance. No DEA scheduling applies. That means pharmacies can fill prescriptions without the quantity-limit concerns that apply to, for example, testosterone products [1].

Comparing Oral Estradiol to Other Estrogen Formulations on Cost

Oral tablets are generally the least expensive delivery method for systemic estradiol in North Dakota. Comparison by monthly cash price:

Oral estradiol tablet (generic): $9 to $15 per month with coupon [1].

Transdermal estradiol patch (generic): $20 to $45 per month depending on dose and patch frequency [1].

Transdermal estradiol gel (Divigel, Estrogel): $60 to $120 per month for branded products; generic options may be lower [1].

Vaginal estradiol ring (Estring): $200 to $300 per 90-day ring; primarily local effect at low dose [1].

For systemic symptom relief at the lowest cost, oral estradiol tablets remain the first choice from a pharmacoeconomic standpoint. Transdermal formulations offer advantages for patients with elevated triglycerides, a personal or family history of venous thromboembolism, or prior gallbladder disease, because bypassing first-pass hepatic metabolism reduces these specific risks [14]. A prescriber should select the formulation based on the patient's metabolic profile, not solely on cost, but cost is a legitimate and often decisive factor for uninsured or underinsured patients.

North Dakota-Specific Resources for Patients

The North Dakota Department of Human Services administers Medicaid and CHIP programs and maintains the preferred drug list at hhs.nd.gov. Patients disputing a Medicaid coverage denial for estradiol can request a state fair hearing through that agency [3].

The North Dakota Insurance Department regulates commercial health plans and can receive complaints about formulary denials or prior authorization delays. Contact information is available at nd.gov/ndins.

The Indian Health Service (IHS) operates facilities in North Dakota serving enrolled tribal members, including the Standing Rock Service Unit, Fort Berthold Service Unit, Turtle Mountain Service Unit, and others. IHS pharmacies may stock oral estradiol and dispense it to eligible patients at no charge [16].

Rural Health Clinics designated under the federal Rural Health Clinic program also qualify for 340B pricing in some cases. North Dakota has a substantial number of RHCs given its population density, and patients in agricultural and ranching communities should ask their local clinic whether 340B pricing applies to their prescriptions [5].

The North Dakota Pharmacy Association can provide referrals to independent pharmacies that offer competitive pricing and personalized counseling on hormone therapy options. For patients who cannot access a prescriber locally, HealthRX's telehealth platform connects North Dakota residents with licensed HRT prescribers and ships to any North Dakota pharmacy or directly to the patient's address.

Patients beginning oral estradiol should have a baseline blood pressure measurement, a documented discussion of personal and family history of breast cancer and thromboembolic disease, and confirmation of intact or absent uterus before the first prescription is filled. If the uterus is intact, a progestogen must be co-prescribed. The most common oral option is micronized progesterone (Prometrium) 100 mg nightly for cyclic therapy or 100 mg nightly continuously for postmenopausal patients [7].

At the lowest currently available cash price of $9 per month for oral estradiol in North Dakota, combined with $15 to $25 per month for generic micronized progesterone, a complete oral HRT regimen costs approximately $24 to $34 per month without insurance, before any coupon or assistance program is applied.